4.7 Article

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study

Journal

CLINICAL INFECTIOUS DISEASES
Volume 74, Issue 6, Pages 1030-1038

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab589

Keywords

SARS-CoV-2; COVID-19; Mali; West Africa; seroprevalence

Funding

  1. Intramural Research Program of the National Institutes of Health
  2. National Institute of Allergy and Infectious Diseases
  3. National Institute of Biomedical Imaging and Bioengineering
  4. National Cancer Institute, National Institutes of Health [HHSN261200800001E]

Ask authors/readers for more resources

This study provides insights into the extent of SARS-CoV-2 exposure and infection in Mali. The results suggest that the cumulative incidence of SARS-CoV-2 in Mali is higher than previously reported, and may now approach hypothetical herd immunity in urban areas. The study also highlights that the epidemiology of the pandemic in this region may primarily involve subclinical infections within background illness rates.
Background The extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure and transmission in Mali and the surrounding region is not well understood. We aimed to estimate the cumulative incidence of SARS-CoV-2 in 3 communities and understand factors associated with infection. Methods Between July 2020 and January 2021, we collected blood samples and demographic, social, medical, and self-reported symptoms information from residents aged 6 months and older over 2 study visits. SARS-CoV-2 antibodies were measured using a highly specific 2-antigen enzyme-linked immunosorbent assay optimized for use in Mali. We calculated cumulative adjusted seroprevalence for each community and evaluated factors associated with serostatus at each visit by univariate and multivariate analysis. Results Overall, 94.8% (2533/2672) of participants completed both study visits. A total of 31.3% (837/2672) were aged <10 years, 27.6% (737/2672) were aged 10-17 years, and 41.1% (1098/2572) were aged >= 18 years. The cumulative SARS-CoV-2 exposure rate was 58.5% (95% confidence interval, 47.5-69.4). This varied between sites and was 73.4% in the urban community of Sotuba, 53.2% in the rural town of Bancoumana, and 37.1% in the rural village of Doneguebougou. Study site and increased age were associated with serostatus at both study visits. There was minimal difference in reported symptoms based on serostatus. Conclusions The true extent of SARS-CoV-2 exposure in Mali is greater than previously reported and may now approach hypothetical herd immunity in urban areas. The epidemiology of the pandemic in the region may be primarily subclinical and within background illness rates. This study demonstrates a large, previously unquantified burden of SARS-COV-2 infection in the community in West Africa. In this young study population, there was limited evidence of severe illness and seropositivity rates that may approach hypothetical herd immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available